Abbott Diabetes Care Inc.

Ex parte reexamination requester·3 ex parte reexams

Abbott Diabetes Care Inc. has requested 3 USPTO ex parte reexaminations. It most often challenges patents owned by DexCom, Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.

Filings by year

3
12

Top patent owners challenged

Outcome track record

How this requester's challenges resolve: claims confirmed, amended, mixed, or fully canceled.

  • Certificate outcome split across every bucket
  • Share of challenges that canceled claims

Challenge metrics

Cancellation rate, average pendency, and the open/closed split across every reexam this requester has filed.

  • Outcome rate of closed challenges
  • Average pendency in months

Examiners & defense counsel

Which examiners decide this requester's challenges, and which firms defend the targeted patents.

  • Most frequent examiners
  • Top opposing counsel

Recent reexaminations (3)

Control #FiledPatentTitleOwnerStatus
90/012,631Sep 14, 20127,835,777DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELSDexCom, Inc.Closed
90/012,628Sep 14, 20126,702,857Membrane for Use with Implantable DevicesDexCom, Inc.Closed
90/012,558Sep 13, 20127,310,544Methods and Systems for Inserting a Transcutaneous Analyte SensorDexCom, Inc.Closed

See the full reexam picture for Abbott Diabetes Care Inc.

Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.